NNNN - Utang jangka dawa perusahaan Anbio Tech

Expanding the distribution network for automated rapid analysis systems is delivering tangible profit for Anbio Biotechnology (NNNN). Management aims to capture the diagnostics market through international certification and innovation. Comparing the company's long-term loans and borrowings chart on GURU.Markets, we see that the metric level is 0.00. Business profitability relies on the growth of the analyzer base and the sale of high-margin consumables.

For an investor in Anbio Biotechnology (NNNN), this metric determines the sustainability of capital-intensive developments of diagnostic systems and analyzers amid volatility. By analyzing the time series of the firm's long-term borrowings, which aggregates all obligations with a maturity exceeding one year, one can assess the risk of rising debt service costs, which directly impacts the profitability of biochemical reagent production and the overall investment attractiveness of the business.